One of our veteran leaders, Dr. Kammili brings forth an impressive legacy of more than 22 years, seamlessly intertwining expertise in Hospital and Clinical Research realms within the Health Care Industry. Holding the prestigious ICH-GCP certification, he is well-versed in both Indian and International Regulatory guidelines, navigating the intricate landscapes of Bioequivalence and Bioavailability studies, Phase 1, Phase II-IV Trials, Medical Writing, Data Management, Pharmacovigilance, and Medical Imaging with finesse.

Currently assuming the role of a distinguished member on the Board of Directors and serving as the Global Head–Business Development, Dr. Kammili oversees International markets encompassing the US, EU, Turkey, S.E. Asia, ROW, and Emerging markets, as well as the Indian domestic market. His active involvement in the comprehensive M&A activities of the Lambda group of companies reflects not only his strategic acumen but also his success as a P&L executive. Dr. Kammili has demonstrated a remarkable ability to cultivate and lead teams to surpass ambitious goals, achieving high profitability. His transformative approach involves the creation of enhanced systems, processes, and synergies within organizations, fostering efficiencies, credibility, and trust among stakeholders.

Beyond his influential contributions to the Clinical Research Domain, Dr. Kammili extends his expertise as a trained Intensivist. His hands-on experience includes valuable assistance in various Interventional Cardiac emergency procedures, ranging from Primary Angioplasties to Coronary Angiograms and Thrombolytic therapies. Notably, he carries the esteemed certifications of a Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) provider, granted by the American Heart Association.